Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Fulgent Genetics, Inc.

Fulgent Genetics, Inc. (FLGT) Stock Overview

Explore Fulgent Genetics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

FLGT●NASDAQ
HealthcareMedical - Diagnostics & Research
$19.90
$0.02(0.10%)
U.S. Market opens in 64h 56m

Fulgent Genetics, Inc. (FLGT)

Meyka AI Score

Z

Key Financials

Market Cap565.2M
P/E Ratio-7.06
EPS (TTM)$0.01
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$19.73
3 Months$21.21
1 Year Target$25.85

FLGT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Fulgent Genetics, Inc. (NASDAQ: FLGT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Fulgent Genetics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FLGT on the NASDAQ shows an RSI of 56.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $25.85 for the NASDAQ listing.

Key metrics behind Fulgent Genetics, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.06 and a market capitalization of 565.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FLGT on the NASDAQ.

Price Performance (NASDAQ: FLGT)

1-Day Change
-0.10%
5-Day Change
6.82%
1-Month Change
0.10%
3-Month Change
14.50%
6-Month Change
-14.15%
Year-to-Date (YTD) Change
-24.25%
1-Year Change
-7.01%
3-Year Change
-40.61%
5-Year Change
-78.92%
All-Time (Max) Change
116.78%

Contact Information

https://www.fulgentgenetics.com
626 350 0537
4978 Santa Anita Avenue, El Monte, CA, 91731

Company Facts

13,150 Employees
IPO DateSep 29, 2016
CountryUS
Actively Trading

Frequently Asked Questions